News Articles Tagged: Tregs

Advancing Cancer Immunotherapy with IKZF2-Targeting Agents

Learn how targeting IKZF2, a key regulator of Tregs, with agents like PLX-4545 is a promising strategy for enhancing anti-cancer immunity.

The Role of IKZF2 Degradation in Modulating the Tumor Microenvironment

Delve into the scientific basis of how IKZF2 degradation, facilitated by agents like PLX-4545, transforms the tumor microenvironment for enhanced anti-cancer immunity.

Oral Tolerance: How Undenatured Type II Collagen May Help Manage Arthritis

Learn about the mechanism of oral tolerance and how undenatured type II collagen (UC-II) leverages this process to potentially alleviate symptoms of inflammatory joint diseases like rheumatoid arthritis and osteoarthritis.

The Impact of Venetoclax on the Immune System in Cancer Therapy

Exploring the emerging research on how Venetoclax (ABT-199) interacts with and potentially enhances the immune system's response against cancer cells.